GMRE 📈 Global Medical REIT - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US37954A2042
GMRE: Healthcare Facilities, Medical Offices, Physician Practices
Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. Web URL: https://www.globalmedicalreit.com
Additional Sources for GMRE Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
GMRE Stock Overview
Market Cap in USD | 614m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 2016-06-29 |
GMRE Stock Ratings
Growth 5y | -16.3% |
Fundamental | 22.4% |
Dividend | 80.4% |
Rel. Strength Industry | -420 |
Analysts | 4.1/5 |
Fair Price Momentum | 7.98 USD |
Fair Price DCF | 24.72 USD |
GMRE Dividends
Dividend Yield 12m | 10.69% |
Yield on Cost 5y | 9.52% |
Annual Growth 5y | 0.98% |
Payout Consistency | 95.7% |
GMRE Growth Ratios
Growth Correlation 3m | -94.9% |
Growth Correlation 12m | 7.1% |
Growth Correlation 5y | -31.9% |
CAGR 5y | -2.28% |
CAGR/Mean DD 5y | -0.09 |
Sharpe Ratio 12m | -1.13 |
Alpha | -55.06 |
Beta | 1.26 |
Volatility | 27.15% |
Current Volume | 1442.6k |
Average Volume 20d | 462.9k |
What is the price of GMRE stocks?
As of December 21, 2024, the stock is trading at USD 7.86 with a total of 1,442,570 shares traded.
Over the past week, the price has changed by -4.57%, over one month by -6.56%, over three months by -16.94% and over the past year by -20.66%.
As of December 21, 2024, the stock is trading at USD 7.86 with a total of 1,442,570 shares traded.
Over the past week, the price has changed by -4.57%, over one month by -6.56%, over three months by -16.94% and over the past year by -20.66%.
Is Global Medical REIT a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Global Medical REIT is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 22.36 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GMRE as of December 2024 is 7.98. This means that GMRE is currently overvalued and has a potential downside of 1.53%.
Neither. Based on ValueRay Fundamental Analyses, Global Medical REIT is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 22.36 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GMRE as of December 2024 is 7.98. This means that GMRE is currently overvalued and has a potential downside of 1.53%.
Is GMRE a buy, sell or hold?
Global Medical REIT has received a consensus analysts rating of 4.10. Therefor, it is recommend to buy GMRE.
Global Medical REIT has received a consensus analysts rating of 4.10. Therefor, it is recommend to buy GMRE.
- Strong Buy: 5
- Buy: 1
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecast for GMRE stock price target?
According to ValueRays Forecast Model, GMRE Global Medical REIT will be worth about 8.6 in December 2025. The stock is currently trading at 7.86. This means that the stock has a potential upside of +9.8%.
According to ValueRays Forecast Model, GMRE Global Medical REIT will be worth about 8.6 in December 2025. The stock is currently trading at 7.86. This means that the stock has a potential upside of +9.8%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 10.8 | 37.9% |
Analysts Target Price | 11.1 | 41.7% |
ValueRay Target Price | 8.6 | 9.8% |